2019
DOI: 10.1093/pm/pnz119
|View full text |Cite
|
Sign up to set email alerts
|

Transcutaneous Supraorbital Stimulation as a Preventive Treatment for Chronic Migraine: A Prospective, Open-Label Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 26 publications
0
17
0
Order By: Relevance
“…In comparison, rPMS led to a clearer decrease depending on the stimulated muscle, which probably points to a considerably higher improvement in the QoL. In this context, the side effects of rPMS tend to be less severe than those reported for VNS and SONS and, consequently, might result in higher acceptance of rPMS and better satisfaction 39,43,45 .…”
Section: Discussionmentioning
confidence: 86%
See 3 more Smart Citations
“…In comparison, rPMS led to a clearer decrease depending on the stimulated muscle, which probably points to a considerably higher improvement in the QoL. In this context, the side effects of rPMS tend to be less severe than those reported for VNS and SONS and, consequently, might result in higher acceptance of rPMS and better satisfaction 39,43,45 .…”
Section: Discussionmentioning
confidence: 86%
“…Despite these promising first results focusing on the peripheral part of the TCC, further insights into rPMS and its central effects for intervention in migraine are lacking. Comparing rPMS to the latest investigations of other available neuromodulative techniques for intervention in migraine, the reduction of migraine attacks and days suffering from headache are generally in a comparable range 33,36,39,43 . In the ESPOUSE study, single-pulse TMS was applied to the occiput by the study participants twice a day during three months as a prophylactic treatment and also as an acute intervention during any migraine attack occurring in this period of time 33 .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The per-protocol (PP) analysis included 21 subjects, while intention-to-treat (ITT) analysis included 24 patients with the exclusion of one patient. In the PP analysis, there was a mean reduction in headache days (−2.43 days, p = 0.05) and moderate to severe headache (−1.29 days, p = 0.06), while in ITT analysis, there was a non-significant mean reduction in headache days (−1.92 days, p = 0.08) and moderate to severe headache days (−1.20 days, p = 0.05) [12]. Among 2000 patients surveyed, there was less than 5% reporting of adverse events, all minor and fully reversible.…”
Section: Electrical Trigeminal Nerve Stimulationmentioning
confidence: 85%